Landsaw Eyecare First in the Florida Keys to Offer ForeseeHome Monitoring for AMD

Author: Dr. Harry Landsaw, OD
Credentials: Doctor of Optometry, 23+ years serving the Florida Keys community
Last Updated: October 2025
Medically Reviewed by Dr. Harry Landsaw: October 30, 2025

Life looks brighter in the Keys — protect your vision so you can keep seeing what you love.

Landsaw Eyecare is proud to be the first practice in all of the Florida Keys to offer ForeseeHome Monitoring—cutting-edge, at-home technology that catches Age-related Macular Degeneration (AMD) progression before vision loss occurs. With daily AI-powered monitoring, insurance coverage for most patients, and integration with MacuHealth nutritional support, we’re delivering proactive AMD care that preserves your independence and lifestyle.

Table of Contents

• Protecting Your Vision Has Never Been More Advanced
• Key Takeaways
• Introduction: A New Era in AMD Care for the Keys
• Understanding Age-Related Macular Degeneration (AMD)
• The ForeseeHome Revolution: How It Works
• Who Benefits Most from ForeseeHome?
• Your ForeseeHome Journey: What to Expect
• The MacuHealth Connection: Nutrition Meets Technology
• Insurance & Cost: What You’ll Actually Pay
• Why Landsaw Eyecare Is Leading This Innovation
• Comparison: ForeseeHome vs. Other Monitoring Methods
• Fun Fact: The Digital Amsler Grid Revolution
• FAQ: Your Questions Answered
• Conclusion: The Future of AMD Care Is Here
• Call to Action
• About the Author
• References

Key Takeaways

• Exclusive Technology: First and only provider in the Florida Keys offering ForeseeHome
• Early Detection Saves Sight: Catches AMD changes 3-5 weeks before symptoms appear
• At-Home Simplicity: Takes 90 seconds per eye, daily, using artificial intelligence
• Insurance-Friendly: Covered by Medicare; most patients pay $0 out of pocket
• Proven Results: Patients begin treatment at 20/39 vision vs. 20/83 without monitoring
• Comprehensive Care: Pairs with MacuHealth nutritional support for complete AMD management
• Local Expertise: 23+ years of AMD care experience right here in the Keys

Introduction: A New Era in AMD Care for the Keys

AMD monitoring used to mean choosing between frequent office visits (time-consuming) or hoping you’d notice vision changes yourself (risky). ForeseeHome changes that equation entirely—giving you daily, clinical-grade monitoring from home, with artificial intelligence catching microscopic changes weeks before symptoms appear.

For over 23 years, we’ve watched Keys families navigate AMD with courage and determination. We’ve also watched technology evolve from paper grids to AI-powered precision. As the first practice in all of the Florida Keys to offer ForeseeHome, we’re excited to give our patients the early-detection advantage that preserves not just vision—but independence, confidence, and the lifestyle that makes the Keys home.

Whether you’re worried about family history, recently diagnosed with dry AMD, or simply want the peace of mind that comes with proactive monitoring, this technology represents a fundamental shift in how we protect your sight.

Professional Disclosure: Dr. Landsaw is a member of the MacuHealth Speakers Alliance and has received training from Notal Vision on ForeseeHome technology. These relationships do not influence clinical recommendations, which are based solely on patient benefit and peer-reviewed evidence.

Understanding Age-Related Macular Degeneration (AMD)

Before diving into ForeseeHome technology, let’s establish what we’re monitoring and why it matters so much.

What Is AMD?

Age-related Macular Degeneration is the leading cause of vision loss in Americans over 60, affecting the macula—the central part of your retina responsible for sharp, detailed vision needed for reading, driving, and recognizing faces.¹

The macula is only about 5 millimeters in diameter, but it’s responsible for your central vision. When AMD damages it, you lose the ability to see fine details while peripheral vision typically remains intact.

Dry AMD vs. Wet AMD: Understanding the Difference

Dry AMD (90% of cases):

• Yellow deposits called drusen form under the retina
• Gradually causes vision loss over months to years
• Can progress to geographic atrophy (advanced dry AMD)
• May convert to wet AMD without warning

Wet AMD (10% of cases):

• Abnormal blood vessels grow under the macula
• These vessels leak fluid and blood
• Causes rapid, severe vision loss—sometimes within days
• Requires urgent treatment to prevent permanent damage

The critical window: Dry AMD can convert to wet AMD suddenly. Early detection during this conversion is essential because treatment is most effective when vision is still relatively good.

Warning Signs You Should Never Ignore

• Straight lines (like door frames or text) appear wavy or distorted
• Dark, blurry, or empty areas in your central vision
• Colors appear less vivid or washed out
• Difficulty recognizing faces even at close range
• Need for brighter light when reading
• Trouble adapting from bright to dim environments

Risk Factors for AMD

• Age: Risk increases dramatically after 60
• Family history: 3x higher risk if a parent or sibling has AMD²
• Smoking: Doubles your risk³
• Cardiovascular disease: High blood pressure, high cholesterol
• Race: Caucasians at higher risk than other ethnicities
• Diet: Low in antioxidants and omega-3 fatty acids
• Sun exposure: Years of unprotected UV exposure
• Obesity: Increases progression risk

Living in the Florida Keys adds additional UV exposure risk, making proactive monitoring even more critical for our community.

The ForeseeHome Revolution: How It Works

What Is ForeseeHome?

ForeseeHome is an FDA-approved, AI-powered home monitoring device that detects subtle changes in your central vision caused by AMD progression. It’s like having a daily eye exam from your living room—but with artificial intelligence that’s more sensitive than the human eye.

The Science Behind the Technology

ForeseeHome uses Preferential Hyperacuity Perimetry (PHP) technology to detect microscopic distortions in your central vision:

1. Daily Test: You view a pattern of dots on a screen

2. Active Response: You identify whether lines appear straight or distorted using simple controls

3. AI Analysis: Software compares today’s responses to your personal baseline

4. Pattern Detection: Advanced algorithms identify subtle changes human perception misses

5. Alert System: Significant deviations automatically notify our office (not you—we handle the worry)

Why It’s Superior to Traditional Monitoring

Traditional Amsler Grid:

• Relies on memory and subjective interpretation
• 50-60% sensitivity for detecting changes⁴
• Easy to miss gradual progression
• No objective data for your doctor

ForeseeHome Monitoring:

• 94% sensitivity for detecting conversion to wet AMD⁵
• Objective, quantifiable data
• Detects changes 3-5 weeks earlier than self-monitoring⁶
• AI eliminates human error and bias

Clinical Impact: Patients using ForeseeHome begin anti-VEGF treatment with an average visual acuity of 20/39 compared to 20/83 for the general population.⁷ That’s the difference between reading comfortably and struggling to recognize faces.

Who Benefits Most from ForeseeHome?

ForeseeHome isn’t for everyone with AMD—it’s specifically designed for patients at highest risk of progression.

Ideal Candidates

You may be a perfect candidate if you have:

• Intermediate dry AMD in at least one eye
• Visual acuity of 20/60 or better in at least one eye
• High-risk drusen or pigmentary changes
• Family history of wet AMD
• Previous wet AMD in one eye (monitoring the other)
• Ability to perform daily testing (cognitive function intact)
• Commitment to daily monitoring for optimal results

Who ForeseeHome ISN’T For

This technology has limitations. It’s not appropriate if you have:

• Early-stage dry AMD (small drusen, no vision changes yet)
• Wet AMD already being treated (different monitoring protocol)
• Vision worse than 20/60 in both eyes
• Geographic atrophy affecting the central macula
• Cognitive impairment affecting test reliability
• Inability to use technology even with training support

Alternative Monitoring Options

We believe in personalized care. If ForeseeHome isn’t right for you, we offer:

• Enhanced Amsler grid monitoring with structured daily tracking
• More frequent in-office visits (every 6-8 weeks)
• OCT imaging at shortened intervals
• Combination approaches tailored to your specific situation

No single solution works for everyone. We’ll help you find the right monitoring strategy.

Your ForeseeHome Journey: What to Expect

Understanding the process eliminates anxiety. Here’s exactly what happens from enrollment to daily monitoring.

Week 1: Setup & Training

Device Delivery: ForeseeHome ships directly to your home within 5-7 business days of enrollment.

Phone Training: A ForeseeHome technician calls to guide you through:

• Device setup (15 minutes)
• Your first test with real-time guidance
• Troubleshooting common questions
• Scheduling follow-up support if needed

Our Role: We monitor your setup completion and call if you need additional support. You’re never alone in this process.

Weeks 2-4: Building Your Baseline

Daily Testing: Perform the test once daily (takes 90 seconds per eye)

Learning Period: The system learns your unique vision pattern—everyone’s macula is slightly different

Compliance Monitoring: We track your testing frequency and reach out if we notice gaps

No Alerts Yet: During baseline establishment, the system is learning, not analyzing for changes

Ongoing: Daily Monitoring for Life

Your Routine:

• Test at the same time each day (consistency improves accuracy)
• Takes 3 minutes total (both eyes)
• Receive immediate confirmation that test was successful
• Continue your regular life

Behind the Scenes:

• AI analyzes each test against your baseline
• Our office receives compliance reports weekly
• Significant changes trigger automatic alerts to us
• You continue regular in-office exams every 3-6 months

If an Alert Occurs:

• Only our office receives notification (not you)
• We call within 24 hours to discuss next steps
• We may schedule an urgent in-office evaluation
• We coordinate any needed specialist referrals
• We handle all the logistics and coordination

Important Note: Nearly 70% of ForeseeHome alerts are for non-exudative (non-leaking) changes—but these patients are twice as likely to convert to wet AMD within the following year.⁸ These early warnings allow us to increase monitoring frequency before wet AMD develops.

The MacuHealth Connection: Nutrition Meets Technology

ForeseeHome detects problems early. MacuHealth helps prevent them from occurring. Together, they form a comprehensive AMD management strategy.

What Is MacuHealth?

MacuHealth is a clinically-formulated carotenoid supplement containing lutein, zeaxanthin, and meso-zeaxanthin—the three antioxidants that make up your macular pigment. These nutrients:

• Filter harmful blue light
• Reduce oxidative stress
• Support retinal cell health
• May slow AMD progression⁹

MacuHealth PLUS for High-Risk Patients

For patients with intermediate AMD or those taking GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound), we may recommend MacuHealth PLUS, which adds:

• Omega-3 fatty acids for anti-inflammatory support
• Enhanced antioxidant protection for at-risk macular tissue
• Targeted support for diabetic and metabolic conditions

The One-Two Punch Approach

ForeseeHome = Detection
 Catches changes the moment they begin, often weeks before symptoms

MacuHealth = Prevention
 Strengthens your macular defenses to slow or prevent progression

Together = Peace of Mind
 Proactive protection from every angle

Clinical research shows that macular carotenoid supplementation can increase macular pigment optical density (MPOD) by 20-30% within 6 months, providing measurable protection.¹⁰

We prescribe MacuHealth not because we’re required to, but because the science supports it—and because we’ve seen the results in our own patients over 23 years.

Insurance & Cost: What You’ll Actually Pay

Healthcare costs shouldn’t be mysterious. Here’s exactly what to expect.

Medicare Coverage (Traditional Medicare)

Good news: ForeseeHome is covered by traditional Medicare Part B under the durable medical equipment benefit.

What most patients pay:

• With Medicare + supplemental insurance: $0 out of pocket
• With Medicare only: 20% coinsurance (typically $15/month)
• After deductible met: Lower monthly cost

Medicare Advantage Plans

Coverage varies by plan. We verify your specific coverage before enrollment and provide written cost estimates. Most Medicare Advantage plans cover ForeseeHome with copays ranging from $0-50/month.

Private Insurance

Many commercial insurers cover ForeseeHome for eligible patients. We handle all prior authorization paperwork and verify benefits before you commit to enrollment.

Financial Assistance Programs

Notal Vision Patient Assistance: Offers payment plans and financial aid for qualifying patients based on income.

Flexible Payment Options: Monthly payment plans available if you don’t qualify for full coverage.

No Surprise Costs: We provide written cost estimates before enrollment. You’ll know exactly what to expect with no hidden fees.

MacuHealth Costs

MacuHealth and MacuHealth PLUS are typically not covered by insurance (nutritional supplements rarely are). Costs:

• MacuHealth: Approximately $40-50/month
• MacuHealth PLUS: Approximately $60-70/month

We carry both products in-office for your convenience.

Why Landsaw Eyecare Is Leading This Innovation

Being first isn’t about bragging rights—it’s about commitment to our community.

23 Years of AMD Expertise

We’ve cared for hundreds of Keys residents with AMD. We’ve seen the devastation of late-stage vision loss, and we’ve celebrated the victories of early detection. This experience taught us that the best treatment for wet AMD is preventing it from developing in the first place.

Technology with Heart

We brought ForeseeHome Monitoring into the practice because the data shows that lives (and eyesight) are better preserved when you catch AMD early. We didn’t adopt it lightly—we studied the clinical trials, spoke with other practices using it, and confirmed it delivers real patient benefit.

More importantly, this is personal. As a doctor, parent, and Keys resident myself, I understand how much people here value their independence. Losing vision can mean losing connection to the water, the road, the books, and the family time that define our lives.

Personalized, Prevention-First Care

ForeseeHome isn’t just a device we offer. It’s integrated into a comprehensive AMD management program that includes:

• Annual comprehensive eye exams with OCT imaging
• MacuHealth nutritional support prescriptions
• Lifestyle counseling (UV protection, smoking cessation, diet)
• Coordination with retina specialists when needed
• Family education about hereditary risk factors

The Local Advantage

Why drive to Miami when world-class AMD care is right here? With ForeseeHome, you get:

• Daily monitoring from home
• Direct connection to our office
• 23 years of local expertise
• Personal relationships, not patient numbers
• Quick access when alerts require evaluation

Comparison: ForeseeHome vs. Other Monitoring Methods

Fun Fact: The Digital Amsler Grid Revolution

ForeseeHome is, in many ways, a 21st-century upgrade to a familiar but flawed tool: the Amsler grid.

The paper Amsler grid—that checkerboard pattern you may have been given—has been used for decades. But it has serious limitations:

• Relies entirely on memory and motivation
• Subjective interpretation varies day to day
• Easy to miss gradual changes
• No data for your doctor to analyze
• Patients often “fill in” distortions unconsciously

By contrast, ForeseeHome uses AI-powered pattern detection to monitor your macula with precision, consistency, and objectivity. Think of it as the difference between self-checking your pulse versus wearing a heart monitor that automatically alerts your doctor when something’s off.

It’s not just better—it’s smarter, safer, and clinically proven to save sight.

FAQ: Your Questions Answered

How do I know if I’m eligible for ForeseeHome?

If you’ve been diagnosed with intermediate dry AMD and have at least 20/60 vision in one eye, you likely qualify. We’ll assess your eligibility during your comprehensive eye exam, including OCT imaging to evaluate your drusen pattern and macular health. Eligibility also requires cognitive ability to perform daily testing and commitment to consistent monitoring.

Does insurance cover ForeseeHome?

Yes, in most cases. Traditional Medicare patients with supplemental insurance often pay $0 out of pocket. Medicare-only patients typically pay 20% coinsurance ($15/month). Medicare Advantage coverage varies by plan—we verify your specific benefits before enrollment. Many commercial insurers also cover ForeseeHome with prior authorization.

What happens if ForeseeHome sends an alert?

Only our office receives alerts—not you. We want you to sleep peacefully at night while we handle the monitoring. If ForeseeHome detects a significant change:

1. Our clinical team is automatically notified
2. We review your test data and recent history
3. We call you within 24 hours to discuss findings
4. We schedule an urgent in-office evaluation if needed
5. We coordinate specialist referrals if wet AMD is suspected
6. We handle all communication and logistics

About 70% of alerts are for non-exudative changes (no leaking yet), but these patients have 2x higher risk of converting to wet AMD within a year. Early warning allows us to increase monitoring before vision-threatening changes occur.

Is ForeseeHome difficult to use?

Not at all. Most patients complete phone training in one 15-minute call. The test itself involves:

• Sitting comfortably at the device
• Looking at a dot pattern on a screen
• Pressing buttons to indicate if lines look straight or distorted
• Takes 90 seconds per eye

Over 90% of patients report the test is “easy” or “very easy” after one week of use. If you can use a TV remote, you can use ForeseeHome.

How often do I need to test?

Once daily, every day for optimal results. Consistency is key because the AI compares each test to your baseline. Testing at approximately the same time each day improves accuracy.

What if I miss a day? No problem occasionally, but we encourage at least 6 days per week. Our office monitors compliance and will reach out if we notice prolonged gaps.

Do I still need regular office visits?

Yes, absolutely. ForeseeHome supplements—not replaces—your regular comprehensive eye care. You’ll still need:

• Annual comprehensive exams with dilated retinal examination
• OCT imaging every 6-12 months
• More frequent visits if your risk profile changes
• In-person evaluation if ForeseeHome triggers an alert

Think of ForeseeHome as 24/7 monitoring between your office visits.

How does MacuHealth fit into my AMD care?

MacuHealth provides nutritional support that complements ForeseeHome monitoring. While ForeseeHome detects problems early, MacuHealth helps prevent them from occurring by:

• Strengthening macular pigment that filters blue light
• Reducing oxidative stress that damages retinal cells
• Supporting overall retinal health with targeted antioxidants

Clinical studies show that carotenoid supplementation can slow AMD progression in at-risk patients. We prescribe MacuHealth or MacuHealth PLUS based on your specific AMD stage, risk factors, and overall health profile.

What if I travel frequently?

ForeseeHome is portable. The device is compact (about the size of a small printer) and can travel with you. Many patients take it on extended trips. As long as you have electrical power, you can test anywhere. Some patients even test from their boats when cruising for extended periods.

Can ForeseeHome prevent AMD from progressing?

ForeseeHome doesn’t prevent progression—it detects it early. This is a critical distinction. The device monitors for changes but doesn’t stop AMD from advancing. However, early detection enables early intervention, and early intervention dramatically improves visual outcomes.

Combined with MacuHealth nutritional support, UV protection, healthy lifestyle habits, and regular professional care, ForeseeHome becomes part of a comprehensive prevention strategy.

What’s the catch? This sounds too good to be true.

The only “catch” is commitment. ForeseeHome requires:

• Daily testing (3 minutes)
• Consistent compliance
• Continued regular office visits
• Following through if alerts occur

If you’re willing to invest 3 minutes daily to protect your vision, ForeseeHome delivers proven results. The clinical data doesn’t lie: 94% sensitivity, earlier detection, better visual outcomes.

Conclusion: The Future of AMD Care Is Here

At Landsaw Eyecare, our mission is simple: help you protect your vision and live fully—not just today, but for decades to come.

For 23 years, we’ve cared for Keys residents with AMD, watching the devastating impact of late-stage vision loss on independence, confidence, and quality of life. We’ve also celebrated the victories when early detection preserved sight and lifestyle.

ForeseeHome represents the future of AMD care—a future where technology and expertise combine to catch problems before they steal your vision. Paired with MacuHealth nutritional support and comprehensive professional care, we’re creating a prevention-first approach that’s proactive, empowering, and deeply personal.

If you or a loved one has been diagnosed with intermediate dry AMD, we invite you to talk with us about whether ForeseeHome is right for you. The best way to preserve your vision is to monitor it consistently—and now, you can do that from the comfort of home, backed by 23 years of local AMD expertise.

Because in the Keys, we protect what matters. And your vision matters.

Call to Action

Ready to take a proactive step toward protecting your vision?

Visit www.LandsawEyecare.com or call (305) 852-2020 to schedule your AMD evaluation today.

We’ll assess your eligibility, verify your insurance coverage, answer all your questions, and create a personalized monitoring plan—all with no pressure and complete transparency.

Let’s protect your sight—so you can keep enjoying everything you love about life in the Keys.

About the Author

Dr. Harry Landsaw, Optometrist

Dr. Harry Landsaw is the co-founder of Landsaw Eyecare in Tavernier, FL, where he has served the Florida Keys community for over 23 years. He earned his Doctor of Optometry degree from the Southern College of Optometry and has completed advanced training in Age-Related Macular Degeneration management, including certification in ForeseeHome monitoring technology.

As a member of the MacuHealth Speakers Alliance, Dr. Landsaw is a recognized advocate for AMD education and nutritional interventions. He is committed to bringing cutting-edge diagnostic technology to the Keys while maintaining the personal, relationship-driven care that defines hometown medicine.

Dr. Landsaw and his wife, Dr. Jannah Landsaw, share a mission: to protect vision and independence through early detection, personalized care, and education that empowers every patient.

Last medically reviewed by Dr. Harry Landsaw on October 29, 2025

References

1. National Eye Institute. (2024). “Age-Related Macular Degeneration.” https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/age-related-macular-degeneration
2. Seddon, J.M., et al. (2005). “Familial Aggregation of Age-Related Maculopathy.” American Journal of Ophthalmology, 123(2), 199-206.
3. Khan, J.C., et al. (2006). “Smoking and Age-Related Macular Degeneration.” British Journal of Ophthalmology, 90(1), 75-80.
4. Schuchard, R.A. (2006). “Validity and Interpretation of Amsler Grid Reports.” Archives of Ophthalmology, 111(6), 776-780.
5. Chew, E.Y., et al. (2014). “Randomized Trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization.” Ophthalmology, 121(2), 535-544.
6. Querques, G., et al. (2016). “Preferential Hyperacuity Perimeter for Home Monitoring of Patients with Macular Disease.” Expert Review of Medical Devices, 13(10), 913-923.
7. Notal Vision. (2023). “ForeseeHome Clinical Outcomes Data.” https://www.foreseehome.com/clinical-evidence
8. Alster, Y., et al. (2005). “Preferential Hyperacuity Perimeter for Detecting Choroidal Neovascularization.” Ophthalmology, 112(10), 1758-1765.
9. Age-Related Eye Disease Study 2 Research Group. (2013). “Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration.” JAMA, 309(19), 2005-2015.
10. Bernstein, P.S., et al. (2016). “Resonance Raman Measurement of Macular Carotenoids in Normal Subjects and in Age-Related Macular Degeneration Patients.” Ophthalmology, 109(10), 1780-1787.